ST
Srinivas Tadepally
About Srinivas Tadepally
Data last updated:
Srinivas Tadepally is a Cfo at Bharat Biotech International Limited (since 2015), Cfo at Chiron Behring Vaccines Private Limited (since 2020) and Designated Partner at Skebio Infra Llp (since 2021). The companies operate in Pharma and Infrastructure and Utilities. The 3 current companies with reported revenue have a combined latest revenue of ₹1,794 Cr; the largest is Bharat Biotech International Limited at ₹1,700 Cr (FY 2025). Earlier, Srinivas Tadepally was a Director at Biovet Private Limited (2013–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 06 Jan 2015 | 1996 | ₹1,700 Cr (FY 2025) | Active | |
| Cfo | 25 Jan 2020 | 1997 | ₹94.53 Cr (FY 2025) | Active | |
| Designated Partner | 15 Dec 2021 | 2021 | ₹5.3 Lakh (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Mar 2013 | 2005 | ₹249 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Srinivas Tadepally
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivas Tadepally
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivas Tadepally
Srinivas Tadepally currently holds 3 directorships: Bharat Biotech International Limited (Cfo, since 06 Jan 2015, revenue ₹1,700 Cr (FY 2025)); Chiron Behring Vaccines Private Limited (Cfo, since 25 Jan 2020, revenue ₹94.53 Cr (FY 2025)); Skebio Infra Llp (Designated Partner, since 15 Dec 2021, revenue ₹5.3 Lakh (FY 2023)).
Srinivas Tadepally was first appointed on 25 Mar 2013 as Director at Biovet Private Limited. The most recent appointment on record is 15 Dec 2021 at Skebio Infra Llp.
The 3 current companies of Srinivas Tadepally that report revenue have a combined latest revenue of ₹1,794 Cr: Bharat Biotech International Limited ₹1,700 Cr (FY 2025); Chiron Behring Vaccines Private Limited ₹94.53 Cr (FY 2025); Skebio Infra Llp ₹5.3 Lakh (FY 2023).
Srinivas Tadepally held 1 earlier board appointment: Biovet Private Limited (Director, 25 Mar 2013 to 07 Sep 2019).
The current boards of Srinivas Tadepally's companies include Kannan Soundararajan (Bharat Biotech International Limited), Krishna Mohan Vadrevu (Bharat Biotech International Limited), Krishna Murthy Ella (Bharat Biotech International Limited), Prathivadibhayankaram Ranganathac Rajagopalan (Bharat Biotech International Limited), Sai Prasad Devarajulu (Bharat Biotech International Limited), Suchitra Ella (Bharat Biotech International Limited), among others.